Epidermolysis Bullosa Acquisita Latest Advances
Find the Latest Research About Epidermolysis Bullosa Acquisita
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 856 publications
Efficacy and Safety of Systemic Therapies for Epidermolysis Bullosa Acquisita: A Systematic Review.
Journal: Journal of cutaneous medicine and surgery
Published: September 23, 2026
Refractory Epidermolysis Bullosa Acquisita Treated With Apremilast.
Journal: The Journal of dermatology
Published: July 23, 2026
Epidermolysis bullosa acquisita improved with use of dupilumab.
Journal: JAAD case reports
Published: July 03, 2026
Depletion of regulatory T cells breaks self-tolerance and induces epidermolysis bullosa acquisita in resistant C57BL/6J mice.
Journal: Journal of autoimmunity
Published: June 16, 2026
Highlights from JAAD Case Reports: August 2026.
Journal: Journal of the American Academy of Dermatology
Published: May 26, 2026
The Therapeutic Challenge in a Rare Case of Immunoglobulin A Type of Epidermolysis Bullosa Acquisita.
Journal: Indian journal of dermatology
Published: May 11, 2026
Long-Term Follow-Up of Epidermolysis Bullosa Acquisita with Fluctuations in Serum Cytokine Levels: A Case Report.
Journal: The Journal of dermatology
Published: March 25, 2026
Co-housing Alters Gut Microbiota and Disease Severity in Experimental Pemphigoid Disease.
Journal: The Journal of investigative dermatology
Published: March 19, 2026
The role of antibody class and target on subepidermal blistering disease phenotype and management.
Journal: Italian journal of dermatology and venereology
Published: March 16, 2026
Selective Complement Inhibition in Anti-p200 Pemphigoid: Immune Infiltrate Profiles and Therapeutic Implications Compared to Bullous Pemphigoid.
Journal: Biomolecules
Published: January 06, 2026
Last Updated: 11/08/2026